CD8+ cytotoxic T lymphocytes are immune cells that can target cancer, and tumor-associated fibroblasts, macrophage type 2 cells and regulatory T cells can form an immune barrier to the anti-tumor immune response mediated by such cells [39]. The gene discussed is CD8A; the disease is cancer.